SIGNAL TRANSDUCTION BY IGM IN B LYMPHOCYTES
SIGNAL TRANSDUCTION BY IGM IN B LYMPHOCYTES
批准号:
3456332
负责人:
Michel C Nussenzweig
金额:
$8.64万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-05-01 至 1998-04-30
关键词:
B cell receptor B lymphocyte biological signal transduction chimeric proteins gene deletion mutation immunoglobulin M immunoprecipitation inositol interleukin 2 molecular cloning phosphorylation phosphotransferases protein engineering protein structure protein transport site directed mutagenesis tissue /cell culture transfection tyrosine
中文摘要
免疫球蛋白是负责以下功能的B细胞抗原受体
检测外来抗原并引发一系列事件
结果是产生特异性抗体。 尽管中心作用,
受体免疫球蛋白在产生免疫反应,很少是
我们对这种受体产生信号的机制还不了解。
细胞信号转导机制的研究进展
免疫球蛋白受体受到两个重要特征的阻碍,
这个受体。 首先,受体的胞质内结构域是
由三种氨基酸组成,没有提供关于
受体功能的机制。 理解的第二个障碍
受体免疫球蛋白是,它们与其他几个
在一个实施方案中,多肽在细胞表面上形成多亚基结构。 两
在这些受体相关多肽中,MB-1和B29已被
参与受体组装和细胞表面转运,此外,
MB-1和B29在受体交联时迅速磷酸化,
但IgM相关蛋白的功能作用尚不清楚。
我们最近成功地重组了受体免疫球蛋白
通过将克隆的受体成分转移到T细胞中发挥作用,
虽然这些实验已经确定了功能性巨噬细胞,
免疫球蛋白抗原受体的生产要求
对于异源细胞,它们不直接解决抗原的问题,
B细胞中受体功能。
拟议研究的长期目标是阐明
膜锚定信号转导的分子要求
B淋巴细胞中免疫球蛋白。 目前的假设是,B29和
MB 1参与B细胞的信号转导,
T和B细胞的信号装置在结构上是同源的。
该项目的第一部分将是建立B细胞系,
表达转染的免疫球蛋白受体。 为了这个目的。我们将
使用缺乏几种受体成分的B细胞系。
在项目的第二部分,我们将研究结构特征
产生增加的酪氨酸磷酸化所需的MB 1和B29,
钙动员、肌醇周转和IL-2分泌
受体交联 这些研究对以下方面有潜在的影响:
了解抗原刺激如何触发
体液免疫
英文摘要
Immunoglobulin is the B cell antigen receptor that is responsible for
detecting foreign antigens and triggering a cascade of events whose end
result is specific antibody production. Despite the central role of
receptor immunoglobulin in the generation of immune responses, little is
known about the mechanism by which this receptor produces a signal.
Progress in understanding the mechanism of signaling by the
immunoglobulin receptor has been hindered by two important features of
this receptor. First the intracytoplasmic domain of the receptor is
composed of three amino acids that offer no specific clues about the
mechanism of receptor function. The second impediment to understanding
receptor immunoglobulins is that they are associated with several other
polypeptides on the cell surface to form a multi-subunit structure. Two
of these receptor associated polypeptides MB-1, and B29 have been
implicated in receptor assembly and cell surface transport, In addition,
both MB-1 and B29 are rapidly phosphorylated upon receptor crosslinking,
but the functional role of the IgM-associated proteins is poorly defined.
We have recently succeeded in reconstituting receptor immunoglobulin
function by transfecting cloned receptor components into T cells and
macrophages, Although these experiments have defined the functional
requirements for the production of an immunoglobulin antigen receptor in
heterologous cells, they do not directly address the problem of antigen
receptor function in B cells.
The long range goal of the proposed research is to elucidate the
molecular requirements for signal transduction by membrane anchored
immunoglobulin in B lymphocytes. The working hypothesis is that B29, and
MB1 are involved in signal transduction in B cells, and that the
signaling apparatus of T and B cells is structurally homologous.
The first part of the project will be to establish B cell lines that
express transfected immunoglobulin receptors. For this purpose. we will
use B cell lines that lack several receptor components.
In the second part of the project we will examine the structural features
of MB1 and B29 required to produce increased tyrosine phosphorylation,
calcium mobilization, inositol turnover and IL-2 secretion in response to
receptor crosslinking. These studies have potential implications for
understanding how an antigenic stimulus triggers the generation of
humoral immunity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The longevity and nature of the anti-SARS-CoV-2 cellular and humoral immune responses
-
批准号:10841240
-
项目类别:
-
资助金额:$98.31万
-
财政年份:2022
-
负责人:Michel C Nussenzweig
-
依托单位:
The longevity and nature of the anti-SARS-CoV-2 cellular and humoral immune responses
-
批准号:10327992
-
项目类别:
-
资助金额:$145.45万
-
财政年份:2022
-
负责人:Michel C Nussenzweig
-
依托单位:
Epitope-focused vaccine strategies against Zika virus
-
批准号:10221136
-
项目类别:
-
资助金额:$81.67万
-
财政年份:2020
-
负责人:Michel C Nussenzweig
-
依托单位:
Project 1
-
批准号:10221139
-
项目类别:
-
资助金额:$81.67万
-
财政年份:2020
-
负责人:Michel C Nussenzweig
-
依托单位:
Class Switch Recombination in B Lymphocytes
-
批准号:10546453
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2019
-
负责人:Michel C Nussenzweig
-
依托单位:
Class Switch Recombination in B Lymphocytes
-
批准号:9546037
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2019
-
负责人:Michel C Nussenzweig
-
依托单位:
Class Switch Recombination in B Lymphocytes
-
批准号:10331863
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2019
-
负责人:Michel C Nussenzweig
-
依托单位:
Admin Core
-
批准号:10454947
-
项目类别:
-
资助金额:$2.99万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Epitope-focused vaccine strategies against Zika virus
-
批准号:10454946
-
项目类别:
-
资助金额:$134.78万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Project 1
-
批准号:9982204
-
项目类别:
-
资助金额:$50.85万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Human monoclonal antibodies for prophylaxis and therapy against the new coronavirus
-
批准号:10265634
-
项目类别:
-
资助金额:$45.83万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Activation of HIV-1 specific B cell precursors using novel vaccine approaches
-
批准号:10540735
-
项目类别:
-
资助金额:$50.85万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Activation of HIV-1 specific B cell precursors using novel vaccine approaches
-
批准号:10300443
-
项目类别:
-
资助金额:$11.73万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Project 1
-
批准号:10454949
-
项目类别:
-
资助金额:$58.89万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Epitope-focused vaccine strategies against Zika virus
-
批准号:9569038
-
项目类别:
-
资助金额:$136.51万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Activation of HIV-1 specific B cell precursors using novel vaccine approaches
-
批准号:10062819
-
项目类别:
-
资助金额:$50.85万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Admin Core
-
批准号:9982202
-
项目类别:
-
资助金额:$3.39万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Admin Core
-
批准号:10216965
-
项目类别:
-
资助金额:$3.39万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Epitope-focused vaccine strategies against Zika virus
-
批准号:10216964
-
项目类别:
-
资助金额:$134.78万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Project 1
-
批准号:10216967
-
项目类别:
-
资助金额:$50.85万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
海外基金